EVEROLIMUS
- Product NDC
- 72603-255
- 11-digit product format
- 726030255
- Labeler code
- 72603
- Product ID
- 72603-255_10865ecf-d37f-4062-ec4e-b8c8a9c36897
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- everolimus
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA214182
- Marketing category
- ANDA
- Marketing start
- 2024-10-01
- Substance
- EVEROLIMUS
- Active strength
- 5 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- EVEROLIMUS
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| EVEROLIMUS | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9HW64Q8G6G |
| Rxcui | 845507, 845515, 998189, 1119400 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72603-255-01 | EVEROLIMUS | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72603-255 | EVEROLIMUS TABLET [NORTHSTAR RXLLC] | 1 | Current NDC, 1 package rows | 20241001_5cfca904-b75c-5a39-8cb9-b99bb421bceb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72603-255-01 | 72603025501 | 30 TABLET in 1 BOTTLE (72603-255-01) | 30 tablet | 2024-10-01 | No | No | Historical |